A novel tissue‐based ß‐catenin gene and immunohistochemical analysis to exclude familial adenomatous polyposis among children with hepatoblastoma tumors
HJ Dubbink, IHIM Hollink… - Pediatric Blood & …, 2018 - Wiley Online Library
Abstract Background The Wnt/β‐catenin pathway plays a central role in the pathogenesis of
most hepatoblastomas (HBs), that is, up to 60–80% carry activating CTNNB1 mutations. HBs …
most hepatoblastomas (HBs), that is, up to 60–80% carry activating CTNNB1 mutations. HBs …
A novel tissue-based ß-catenin gene and immunohistochemical analysis to exclude familial adenomatous polyposis among children with hepatoblastoma tumors
HJ Dubbink, IHIM Hollink, CA Valente… - Pediatric blood & …, 2018 - pubmed.ncbi.nlm.nih.gov
Background The Wnt/β-catenin pathway plays a central role in the pathogenesis of most
hepatoblastomas (HBs), that is, up to 60-80% carry activating CTNNB1 mutations. HBs can …
hepatoblastomas (HBs), that is, up to 60-80% carry activating CTNNB1 mutations. HBs can …
[PDF][PDF] A novel tissue-based ß-catenin gene and immunohistochemical analysis to exclude familial adenomatous polyposis among children with hepatoblastoma …
HJ Dubbink, IHIM Hollink, CA Valente, W Wang, P Liu… - scholar.archive.org
Abstract Background: The Wnt/𝛽-catenin pathway plays a central role in the pathogenesis of
most hepatoblastomas (HBs), that is, up to 60–80% carry activating CTNNB1 mutations. HBs …
most hepatoblastomas (HBs), that is, up to 60–80% carry activating CTNNB1 mutations. HBs …
[PDF][PDF] A novel tissue-based ß-catenin gene and immunohistochemical analysis to exclude Familial Adenomatous Polyposis among children with hepatoblastoma …
HJ Dubbinka, IHIM Hollinkb, CA Valentea… - Targeting Wnt/β-catenin … - core.ac.uk
Abstract Background: The Wnt/β-catenin pathway plays a central role in the pathogenesis of
most hepatoblastomas, ie up to 60-80% carry activating CTNNB1 mutations …
most hepatoblastomas, ie up to 60-80% carry activating CTNNB1 mutations …
A novel tissue-based ß-catenin gene and immunohistochemical analysis to exclude familial adenomatous polyposis among children with hepatoblastoma tumors
EJ Dubbink, I Hollink, C Avenca Valente… - Pediatric Blood & …, 2018 - repub.eur.nl
Background: The Wnt/β-catenin pathway plays a central role in the pathogenesis of most
hepatoblastomas (HBs), that is, up to 60–80% carry activating CTNNB1 mutations. HBs can …
hepatoblastomas (HBs), that is, up to 60–80% carry activating CTNNB1 mutations. HBs can …
A novel tissue-based ß-catenin gene and immunohistochemical analysis to exclude familial adenomatous polyposis among children with hepatoblastoma tumors.
HJ Dubbink, I Hollink, W Wang, P Liu… - Pediatric Blood & …, 2018 - europepmc.org
Background The Wnt/β-catenin pathway plays a central role in the pathogenesis of most
hepatoblastomas (HBs), that is, up to 60-80% carry activating CTNNB1 mutations. HBs can …
hepatoblastomas (HBs), that is, up to 60-80% carry activating CTNNB1 mutations. HBs can …
[PDF][PDF] A novel tissue-based ß-catenin gene and immunohistochemical analysis to exclude familial adenomatous polyposis among children with hepatoblastoma …
HJ Dubbink, IHIM Hollink, CA Valente, W Wang, P Liu… - core.ac.uk
Abstract Background: The Wnt/𝛽-catenin pathway plays a central role in the pathogenesis of
most hepatoblastomas (HBs), that is, up to 60–80% carry activating CTNNB1 mutations. HBs …
most hepatoblastomas (HBs), that is, up to 60–80% carry activating CTNNB1 mutations. HBs …